Evolving global norm/policy on the interface between trade and health: An insight into the WHO FCTC negotiations by the Conference of the Parties
Methods: Using process tracing approach, we triangulate observations of FCTC Conference of the Parties (COP) meetings, interviews, and archival documents retrieved through snowball method. We analyze data to identify major decision-making venues for trade-health and themes underlying decisions.
Results: Beginning with 2002 WHO-WTO's report during the FCTC negotiations to reconcile trade rules with public health, there have been sustained efforts within WHO and UN to address the issue, culminating in COP resolution on Trade and Health issues during the 6th meeting in 2014 in Moscow, Russia. This has led to increasing convergence around three core ideas: 1) minimization of tobacco industry use of trade/investment agreements against tobacco control; 2) multi-sectoral collaboration; and 3) health impact as integral part of trade/investment negotiations.
Conclusion: Deemed in early 2000s as mutually exclusive, nation-states have continued to negotiate the trade-health issue, leading to convergence on the need to incorporate health impact in trade/health negotiations. This bode well for the protection of health policies against tobacco industry threats.
Learning Areas:Advocacy for health and health education
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Public health or related research
Analyze and trace how the issue of trade and health has evolved Identify the key rationale for inter-state collaboration on trade and health Generate evidence to inform policy and advocacy activities pertaining to trade and health
Keyword(s): Tobacco Control, Public Health Policy
Qualified on the content I am responsible for because: I conduct research in tobacco use and control, including the interface between trade and health.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.